CX 2018 Digest
In 2018, CX marked 40 Years of Looking Forward and started a new cycle of Controversies, Challenges, and Consensus. Highlights of the Symposium included the presentation, for the first time, of the EVRA (Early venous reflux ablation) results, a CX Great Debate on whether “Endovascular first for critical limb ischaemia is a concept without evidence”, a review of the optimal approaches for follow-up after endovascular aneurysm repair (EVAR), and data from the Stroke Thoracic Endovascular Procedures (STEP) collaboration.
The CX 2018 Digest discusses these highlights as well as the other key topics discussed at this year’s Symposium. Furthermore, it has the “take-home” messages by members of the CX Programme Organising Board.
As always, audience participation and interaction were important features of CX, and the CX 2018 Digest features the voting results from the four days of the symposium. Statistics highlighting attendance to the event are also available. In 2018, CX had a strong attendance with just over 4,000 participants from a record-breaking 86 countries.